Susquehanna International Group’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Buy |
117,769
+46,847
| +66% | +$75K | ﹤0.01% | 5590 |
|
|
2025
Q1 | $86.5K | Sell |
70,922
-10,353
| -13% | -$12.6K | ﹤0.01% | 5897 |
|
|
2024
Q4 | $154K | Buy |
+81,275
| New | +$154K | ﹤0.01% | 5472 |
|
|
2024
Q3 | – | Sell |
-15,678
| Closed | -$116K | – | 6282 |
|
|
2024
Q2 | $116K | Buy |
+15,678
| New | +$116K | ﹤0.01% | 5041 |
|
|
2024
Q1 | – | Sell |
-2,664
| Closed | -$21K | – | 6309 |
|
|
2023
Q4 | $21K | Buy |
+2,664
| New | +$21K | ﹤0.01% | 5668 |
|
|
2023
Q3 | – | Sell |
-2,711
| Closed | -$94.3K | – | 6122 |
|
|
2023
Q2 | $94.3K | Sell |
2,711
-1,709
| -39% | -$59.5K | ﹤0.01% | 5023 |
|
|
2023
Q1 | $96.3K | Buy |
4,420
+3,345
| +311% | +$72.9K | ﹤0.01% | 5267 |
|
|
2022
Q4 | $23.2K | Sell |
1,075
-720
| -40% | -$15.6K | ﹤0.01% | 5328 |
|
|
2022
Q3 | $44K | Buy |
+1,795
| New | +$44K | ﹤0.01% | 5533 |
|
|
2022
Q2 | – | Sell |
-921
| Closed | -$33K | – | 6427 |
|
|
2022
Q1 | $33K | Buy |
+921
| New | +$33K | ﹤0.01% | 5397 |
|
|
2021
Q2 | – | Sell |
-8,292
| Closed | -$373K | – | 5750 |
|
|
2021
Q1 | $373K | Buy |
+8,292
| New | +$373K | ﹤0.01% | 4140 |
|
|
2020
Q1 | – | Sell |
-585
| Closed | -$7K | – | 4912 |
|
|
2019
Q4 | $7K | Sell |
585
-243
| -29% | -$2.91K | ﹤0.01% | 3909 |
|
|
2019
Q3 | $25K | Buy |
+828
| New | +$25K | ﹤0.01% | 4273 |
|
|
2019
Q1 | – | Sell |
-712
| Closed | -$57K | – | 4104 |
|
|
2018
Q4 | $57K | Sell |
712
-257
| -27% | -$20.6K | ﹤0.01% | 3306 |
|
|
2018
Q3 | $152K | Buy |
+969
| New | +$152K | ﹤0.01% | 2845 |
|
|
2018
Q2 | – | Sell |
-211
| Closed | -$30K | – | 4381 |
|
|
2018
Q1 | $30K | Buy |
+211
| New | +$30K | ﹤0.01% | 3188 |
|